Immunovia AB (OSTO:IMMNOV) Preferred Dividends : kr0.00 Mil (TTM As of Sep. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Immunovia AB Preferred Dividends?

Preferred dividend is a dividend that is accrued and paid on a company's preferred shares. Immunovia AB's preferred dividends for the three months ended in Sep. 2024 was kr0.00 Mil. Its preferred dividends for the trailing twelve months (TTM) ended in Sep. 2024 was kr0.00 Mil.

Immunovia AB Preferred Dividends Historical Data

The historical data trend for Immunovia AB's Preferred Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunovia AB Preferred Dividends Chart

Immunovia AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Preferred Dividends

Get a 7-Day Free Trial

Immunovia AB Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Preferred Dividends	Get a 7-Day Free Trial															-	-	-	-	-

Immunovia AB Preferred Dividends Calculation

A dividend that is accrued and paid on a company's preferred shares.

Immunovia AB (OSTO:IMMNOV) Preferred Dividends Explanation

In the event that a company is unable to pay all dividends, claims to preferred dividends take precedence over claims to dividends that are paid on common shares.

Preferred Dividends for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

Immunovia AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Immunovia AB (OSTO:IMMNOV) » Definitions » Preferred Dividends

Comparable Companies

Traded in Other Exchanges

0G8X:UK

Address

Medicon Village, Scheelevagen 8, Lund, SWE, 223 63

Website

https://www.immunovia.com

Immunovia AB molecular diagnostic company. It develops and commercializes diagnostic tools for complex forms of cancer and autoimmune diseases. Its technology platform IMMray (TM), is based on antibody microarray analysis. The company is currently developing its next-generation blood test to detect pancreatic cancer in high-risk individuals. IMMray platform is dedicated to the early detection of pancreatic cancer.

Immunovia AB Headlines

No Headlines